CEimpact Podcast

The Updated AAAAI Guidelines on Drug Allergies

Drug allergies are a common challenge for all prescribers, patients, and pharmacies. They are associated with increased costs, adverse effects, and extended hospitalizations. Join host Geoff Wall as he reviews the newly released AAAI guidelines on drug allergies.

The GameChanger
Over 90% of patients claiming a penicillin allergy are not allergic. Sulfamethoxazole desensitization is largely not needed. A thorough evaluation of patient allergies with testing may help establish true allergies in patients and help optimize pharmacotherapy.

Show Segments
00:00 - Introductions
01:55 - Changes in Classifications
07:35 - The GameChanger: Beta-Lactam Allergy Approach
21:05 - Sulfonamide Allergy Approach
27:04 - Non-Steroidal Allergy Approach
30:05 - Connecting to Practice: Applying these Changes
30:58 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
A 2022 practice parameter update.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss approaches to a patient with a claimed penicillin allergy who requires a beta lactam
2. Discuss the protocol for desensitization for a sulfonamide allergic patient when a sulfonamide is required

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-133-H01-P
Initial release date: 04/03/2023
Expiration date: 04/03/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Although the numbers may be low, COVID-19 and other illnesses remain a significant threat to patients. The role of masks in preventing SARS-CoV-2 spread has been politicized since the beginning. A new meta-analysis purports to answer the question of mask effectiveness. Join host Geoff Wall, with guest Jake Galdo, as they deep dive into the article and evaluate the science.

The GameChanger
A new meta-analysis suggests that mask mandates do not affect the prevention and spread of COVID-19. However, the study has numerous limitations and errors, making its interpretation difficult.

Show Segments
00:00 - Introductions
01:31 - Pros and Cons of a Meta-Analysis
06:31: Looking at the Analysis
10:24 - The GameChanger: Jefferson et al. Results
11:24 - Connecting to Practice: Recognizing Limitations
28:43 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

References and Resources
Jefferson T, Dooley L, Ferroni E, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses (Review). Cochrane Library. 

Novella S. Masks Revisited. Science Based Medicine.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the pros and cons of a meta-analysis
2. Describe the limitations of the Jefferson et al meta-analysis

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-119-H01-P
Initial release date: 03/22/2023
Expiration date: 03/22/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Pharmacogenomics have long held the promise of using personalized information for drug selection to maximize efficacy and minimize adverse reactions. A new study evaluates the routine use of pharmacogenomic testing to improve safety in a wide range of medications. Join host, Geoff Wall, as he evaluates personalized medicine.

The GameChanger
Most studies using routine pharmacogenomic testing in clinical practice have not been significant. However, a new study found a 12 panel pharmacogenomic test did decrease the incidence of patient reported adverse effects compared to usual care. Several limitations still exist preventing widespread implementation.

Show Segments
00:00 - Introductions
01:38 - Genomic Guided Therapy to Date
05:05 - Importance of Genomic Variations
08:37 - Looking at the Study
21:20 - The GameChanger: Swen et al Results
27:50 - Connecting to Practice: Current Barriers to Pharmacogenomic Testing
30:38- Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.

Clinical Pharmacogenomics Implementation Consortium.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current barriers to routine use of pharmacogenomic testing
2. Discuss issues and results of the Swen et al study on pharmacogenomics

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-118-H01-P
Initial release date: 03/20/2023
Expiration date: 03/20/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Pharmacy learners - IPPE, APPE, Residents - may not always be forthcoming with honest feedback. But they know what they appreciate (or don't) in a learning experience. As a preceptor, your approach to teaching has a huge impact on student learning.

We asked two 4th year pharmacy learners to share what matters most to them in a preceptor. Their answers may surprise you! Listen in to learn what students most value in their learning experiences and gather some strategies you can use to enhance your teaching and mentor in an impactful way for your learners. 

Host
Kathy Schott, PhD
CEimpact
 
Guests
Lily Gardner, PharmD Candidate 2023
Drake University

Keaton Higgins, PharmD Candidate 2023
University of Iowa

Get CE
Click here to access the course

CE Information

At the end of this course, preceptors will be able to:

1. Identify practices that pharmacy learners most value in their preceptors and why

2. Describe effective strategies to enhance learning in the pharmacy education experience you provide

UAN: 0107-0000-23-116-H99-P
 Release Date: 03/15/2023
 Expiration Date: 03/15/2026
 The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

• Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
• Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Want more information on this and related topics? 

Check out the full course created by Dr. Cox on this topic: Using Feedback to Improve Your Precepting, and learn what you can do to help facilitate better feedback from your learners.

This book is a great resource for building feedback skills – Thanks for the Feedback: The Science and Art of Receiving Feedback Well. I’ve read this book and there’s something in it for everyone – from a teacher, mentor, preceptor, parent, partner, or spouse. Check out the LINK!

 As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask you experiential program director if you are a member so that you can access it all for free! 

Follow CEimpact on Social Media:
LinkedIn
Instagram

For the past two decades, large amounts of isotonic fluids have been the first step in treating septic shock despite adverse events of fluid overload, coagulopathy, and pulmonary edema. A new NIH study evaluates this strategy. Join host, Geoff Wall, with guest, Matt Trump, DO, as they evaluate initial septic shock management.

The GameChanger
Liberal fluid management (30 mL/Kg) in the early phase of septic shock may not result in lower mortality than a more restrictive strategy. However, vasopressor predominant strategy may be used in its place.

Show Segments
00:00 - Introductions
01:08 - Background on Fluid Administration in Septic Shock
05:44 - Looking at the Study
15:55 - The GameChanger: Shapiro et al Results
21:21 - Connecting to Practice: What Should We Takeaway
34:31 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Matt Trump, DO
Iowa Clinics

References and Resources
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the background of fluid administration in septic shock
2. Describe the results of the Shapiro et al study

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-103-H01-P
Initial release date: 03/13/2023
Expiration date: 03/13/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Every January, the American Diabetes Association publishes the Standards of Care in Diabetes. The guidelines are a living document and change throughout the year; however, the January update is the seminal changes for the entire document. Join host, Geoff Wall, with guest, Jake Galdo, as they discuss what’s new and great in the guidelines.

The GameChanger
In addition to medication recommendations, the guidelines now emphasize the role of Community Health Workers in the management of health-related disparities affecting patients with diabetes. Pharmacotherapy continues to be driven by comorbid conditions and the impact of clinical outcomes, like a cardiovascular or renal disease.

Show Segments
00:00 - Introductions
01:59 - Prevention and Delay of Type 2 Diabetes
08:12 - Vaccines and Diabetes
10:49 - Continuous Glucose Monitoring Goals
17:21 - Glycemic Treatment Updates
19:25 - Lipid Goals and Treatment
20:39 - The GameChanger: Treatment Recommendations with Comorbid Conditions
23:49 - Connecting to Practice: Comorbid Driven Therapy
27:31 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

References and Resources
American Diabetes Association. Standards of Care in Diabetes-2023 Abridged for Primary Care Providers.
 
Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership


CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the goal for continuous glucose monitoring in diabetes patients
2. Describe the lipid goals in patients with diabetes and treatment recommendations
3. Describe treatment recommendations for patients with diabetes and chronic kidney disease

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-102-H01-P
Initial release date: 03/06/2023
Expiration date: 03/06/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Furosemide is the most prescribed loop diuretic for heart failure; however, furosemide’s pharmacokinetic parameters are less than ideal compared to other loop diuretics. Join host, Geoff Wall, as he evaluates the first randomized controlled trial comparing loop diuretics in heart failure.

The GameChanger
Torsemide has potential pharmacokinetic advantages compared to furosemide in the treatment of heart failure. However, a recent study did not find meaningful differences in clinical outcomes when comparing loop diuretics for the treatment of heart failure.

Show Segments
00:00 - Introduction
01:00 - Current Loop Diuretic Use
02:21 - Furosemide vs Torsemide Pharmacokinetics
04:58 - Looking at the TRANSFORM-HF Study
14:54 - The GameChanger: TRANSFORM-HF Outcomes
19:16 - Connecting to Practice: Picking Between the Two
21:52 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. List the pharmacokinetic differences between furosemide and torsemide
2. Discuss the findings of the Mentz et al study evaluating loop diuretics

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-101-H01-P
Initial release date: 02/27/2023
Expiration date: 02/27/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Routine pediatric vaccines are declining and 97% of pediatric influenza deaths are in unvaccinated children. Join host Geoff Wall, with guest Jake Galdo, as they discuss what the heck is happening with pediatric vaccines and how the healthcare community can step up.

The GameChanger
The Advisory Committee on Immunization Practices provides recommendations for routine vaccines for all persons. Pharmacists are an integral part of ensuring adherence to vaccine schedules. Differences in state scope of practice may influence what vaccines may be administered, but not what vaccines can be recommended.

Show Segments
00:00 - Introductions
00:53 - Pediatric Vaccine Coverage
02:51 - Connecting to Practice: How Pharmacists Can Help
14:21 - The GameChanger: Pediatric COVID Vaccines
26:22 - Closing Remarks


Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

References and Resources
Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2021-22 School Year.
 
Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the current state of pediatric vaccinations in the US
2. Describe clinical information to be collected during pediatric vaccinations

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-100-H01-P
Initial release date: 02/20/2023
Expiration date: 02/20/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

As preceptors, sometimes one of the hardest things we do is give feedback. What about when we receive it? Listen to learn how to engage students in ways that result in meaningful feedback you can use to improve your teaching. You're putting in the work. Why not make it as impactful as possible for your learners?

This week I’m speaking with Nick Cox – a faculty member and preceptor in an ambulatory care setting – on the topic of feedback – how to invite it, how to prepare to receive it, and what to do with it when you like it – or not. 

 As part of our discussion, Nick refers to this book – Thanks for the Feedback: The Science and Art of Receiving Feedback Well. I’ve read this book, and there’s something in it for everyone – from a teacher, mentor, preceptor, parent, partner, or spouse. Check out the Here!

Host
Kathy Schott, PhD
CEimpact
 
Guest
Nicholas Cox, PharmD BCACP
Assistant Professor (Clinical)
University of Utah

Get CE
Click here to access the course

CE Information

At the end of this course, preceptors will be able to:

1. List common barriers that prevent learners from providing meaningful feedback to preceptors.

2. Describe ways to create a learning environment where students feel they can safely offer feedback.

UAN: 0107-0000-23-092-H99-P
Release Date: 02/15/2023
Expiration Date: 02/15/2026
The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:

• Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
• Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

 Want more information on this and related topics? 

Check out the full course created by Dr. Cox on this topic: Using Feedback to Improve Your Precepting, and learn what you can do to help facilitate better feedback from your learners.

 As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask your experiential program director if you are a member so that you can access it all for free!

Follow CEimpact on Social Media:
LinkedIn
Instagram

Patient use of any anticoagulation during an acute stroke is a contraindication for the use of thrombolytics or clot busters. Recent meta-analyses and animal studies raise the question of this contraindication. Join guest, Geoff Wall, as he examines the data on Direct Oral Anticoagulants (DOACs) and thrombolytics.

The GameChanger
DOACs have a significantly smaller intracranial hemorrhage (ICH) risk compared to warfarin and this benefit may translate to risk of bleed with thrombolytics. A new study found a numerically decreased risk of ICH in patients with DOACs compared to controls.

Show Segments
00:00 - Introductions
01:07 - Current Practices with Thrombolytics
05:05 - Looking at the Study
19:45 - The GameChanger: Decreased ICH Risk?
23:30 - Study Limitations
26:11 - Connecting to Practice
27:01 - Closing Remarks

Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:

1. Discuss the theory about why DOACs may not increase risk of intracranial bleed in stroke patients receiving thrombolytics
2. Describe the limitations of the Meinel et al study

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-064-H01-P
Initial release date: 02/13/2023
Expiration date: 02/13/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram